Joinn Laboratories (China) Co's revenue for the
three
months ended in Dec. 2023 was ¥789 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ¥2,376 Mil.
Joinn Laboratories (China) Co's Revenue per Share for the
three
months ended in Dec. 2023 was ¥1.04.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3.51.
Warning Sign:
Joinn Laboratories (China) Co Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Joinn Laboratories (China) Co was 5.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 22.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 38.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 28.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 12 years, Joinn Laboratories (China) Co's highest 3-Year average Revenue per Share Growth Rate was 46.70% per year. The lowest was 13.50% per year. And the median was 25.60% per year.
Joinn Laboratories (China) Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Joinn Laboratories (China) Co's Revenue
For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joinn Laboratories (China) Co's Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Revenue distribution charts can be found below:
* The bar in red indicates where Joinn Laboratories (China) Co's Revenue falls into.
Joinn Laboratories (China) Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,376 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joinn Laboratories (China) Co (SHSE:603127) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Joinn Laboratories (China) Co Revenue Related Terms
Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Joinn Laboratories (China) Co (SHSE:603127) Business Description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Joinn Laboratories (China) Co (SHSE:603127) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:603127 has been successfully added to your 